EMMA - Emmaus Life Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 7/1/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-82.92%
S&P500 52-Week Change 35.18%
52 Week High 311.7600
52 Week Low 30.8500
50-Day Moving Average 31.6091
200-Day Moving Average 31.5883

Share Statistics

Avg Vol (3 month) 322.23k
Avg Vol (10 day) 318.47k
Shares Outstanding 548.47M
Float 29.24M
% Held by Insiders 121.59%
% Held by Institutions 10.48%
Shares Short (Aug 14, 2019) 441.22k
Short Ratio (Aug 14, 2019) 40.48
Short % of Float (Aug 14, 2019) 40.09%
Short % of Shares Outstanding (Aug 14, 2019) 40.09%
Shares Short (prior month Jun 27, 2019) 433.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 17, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)-15.20%

Management Effectiveness

Return on Assets (ttm)-3.24%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)24.1M
Revenue Per Share (ttm)0.63
Quarterly Revenue Growth (yoy)24.60%
Gross Profit (ttm)14.31M
Net Income Avi to Common (ttm)-77.97M
Diluted EPS (ttm)-2.0890
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.19M
Total Cash Per Share (mrq)0.85
Total Debt (mrq)23.77M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.47
Book Value Per Share (mrq)-0.37

Cash Flow Statement

Operating Cash Flow (ttm)-5.99M
Levered Free Cash Flow (ttm)9.96M